Show
Sort by
-
Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin
-
Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action
-
Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y
-
Substantia nigra is an anticonvulsant site of action of topiramate in the focal pilocarpine model of limbic seizures
-
Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats
-
Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity
-
Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine
-
In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin
-
Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures
-
Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D2 and 5-HT1A receptors